betnovate scalp application 0.1% w/w cutaneous solution
synvisc - synovial fluid supplementation substance
sanofi-aventis australia pty ltd - 44757 - synovial fluid supplementation substance - a sterile, nonpyrogenic, elastoviscous fluid containing hylan polysaccharide hydrated in physiological saline. synvisc is only intended for intra-articular use to treat pain associated with osteoarthritis of the knee.
synvisc-one (hylan g-f 20) - synovial fluid supplementation substance
sanofi-aventis australia pty ltd - 44757 - synovial fluid supplementation substance - a sterile, nonpyrogenic, elastoviscous fluid containing hylan polycaccharide (hylan polymer 8.0 mg/ml) hydrated in physiological saline. synvisc-one is only intended for intra-articular use to treat pain associated with osteoarthritis of the knee.
mycoplasma synoviae - antigen nobilis
intervet australia pty limited - mycoplasma synoviae strain atcc wvu-1853 - diagnostic agents - poultry | turkeys | breeder | breeders | broiler | broiler breeder | chickens | chicks | chooks | day old chicks | hatchlings | - not applicable (vet)
durolane - synovial fluid supplementation substance
emergo asia pacific pty ltd t/a emergo australia - 44757 - synovial fluid supplementation substance - durolane is a sterile, transparent viscoelastic gel supplied in a 3 ml glass syringe and contains 20 mg/ml of stabilized hyaluronic acid. durolane is a single injection, single dose preparation and should only be injected once per treatment course. injections of hyaluronic acid in the joint, is intended to restore the viscosity and elasticity and may diminish pain and improve mobility of the joint. durolane is intended to be used for intra-articular injection for the symptomatic treatment of mild to moderate knee or hip osteoarthritis and mild to moderate osteoarthritis pain in the ankle, shoulder, elbow, wrist, fingers, and toes. durolane is also indicated for pain following joint arthroscopy in the presence of osteoarthritis within three months of the procedure.
betnova-n cream
nipro jmi pharma limited - betamethasone + neomycin sulphate - cream - 100 mg + 500 mg/100 gm
betnova-n ointment
nipro jmi pharma limited - betamethasone + neomycin sulphate - ointment - 100 mg + 500 mg/100 gm
betnovate-c 20/30;g crm
gsk - betamethasone valerate,clioquinol - crm - 0.12,3;% - 20/30;g
betnovate-gm 20g crm
gsk - betamethasone valerate,gentamicin sulph.,miconazole nit. - crm - 0.12,0.1,2;%;w/w - 20g